MUCINOSES

Interactive Saudi Board Exam Review

Overview Classification Inflammatory Types Staining Techniques Comparisons Leonine Facies

Overview of Mucinoses

Core Concepts

Mucinoses are disorders characterized by abnormal mucin accumulation in the skin.

What is Mucin?

  • Dermal extracellular matrix component
  • Produced by fibroblasts
  • Jelly-like acid glycosaminoglycans (GAGs)
  • Hyaluronic acid is the most important component:
    • Never sulfated
    • No core protein
    • Not packaged in Golgi
    • High in fetal skin
  • Mucin absorbs 1000x its weight in water → maintains dermal salt & water balance

Histologic Features

  • Appears as bluish material between collagen bundles or empty spaces in dermis
  • Special stains: Colloidal iron, Alcian blue, Toluidine blue (CAT); PAS negative
  • Fixation: Absolute alcohol better than normal saline for mucin detection

✨ Mnemonic: "CAT" Stains for Mucin ✨

Colloidal iron (blue)

Alcian blue

Toluidine blue (red/purple)

Remember: PAS is negative for mucin!

Pathophysiology & Factors

  • Stimulators: Serum immunoglobulins, TNF-α, TGF-β
  • IL-1 especially important in tumid lupus

Classification of Mucinoses

Primary Mucinoses: Mucin deposition is the main feature

  1. Inflammatory/Degenerative:
    • Dermal: Scleromyxedema, Lichen myxedematosus, Self-healing cutaneous mucinosis, Scleredema, Localized/Generalized myxedema, Reticular erythematous mucinosis, Papulonodular mucinosis, Cutaneous focal mucinosis, Digital mucous cyst
    • Follicular: Follicular mucinosis (Pinkus), Urticaria-like follicular mucinosis
  2. Hamartomatous/Neoplastic: Mucinous nevus, (Angio)myxoma

Secondary Mucinoses: Mucin is an additional feature in another disorder

  • Epithelial mucinosis: BCC, rarely SCC, KA, verruca, seborrheic keratosis, MF
  • Dermal mucinosis: Granuloma annulare, LE, dermatomyositis > scleroderma, mesenchymal tumors (e.g., myxosarcoma, DFSP), neural tumors (neurofibroma)
  • Follicular mucinosis: Mycosis fungoides, eczematous dermatoses, rare: LE, insect bites, imatinib, familial reticuloendotheliosis

✨ Mnemonic: "LDS" for Secondary Dermal Mucinosis ✨

Lupus erythematosus

Dermatomyositis

Scleroderma

Inflammatory/Degenerative Dermal Mucinoses

Scleromyxedema

AKA papular mucinosis, Arndt-Gottron syndrome

  • Idiopathic, ↑ mucin + sclerosis ("scler-myx")
  • Nearly all patients have IgG lambda monoclonal gammopathy
  • Middle-aged adults, both sexes affected
Clinical Features
  • Numerous 2–3 mm firm waxy papules in linear, symmetric arrays
  • Shiny, indurated skin; head/neck, upper trunk, hands, forearms, thighs
  • Deep farrowing (especially glabella); "Shar-Pei sign" (back); "Doughnut sign" (PIP)
  • Severe face involvement → leonine facies
  • Mucous membranes and scalp typically spared (vs amyloidosis)
Systemic Features & Complications
  • IgG lambda monoclonal gammopathy, <10% progress to myeloma
  • Dermato-neuro syndrome: sudden worsening, flu-like symptoms, fever, encephalopathy → can progress to coma
Pathology & Treatment

Pathology:

  • ↑ mucin, ↑ collagen, irregular fibroblasts (hallmarks)
  • DDx: Systemic sclerosis, scleredema (look for linear infiltrative papules)

Treatment:

  • Rule out thyroid disease
  • Rule out systemic involvement & dermato-neuro syndrome
  • IVIG = first line
  • Thalidomide/systemic steroids (2nd line, can combine with IVIG)
  • Autologous HSCT (3rd line)
  • Other options: bortezomib+dexamethasone (post-transplant), PUVA, UVA1, retinoids, cyclosporine, electron beam, plasmapheresis, ECP (variable results)

Lichen Myxedematosus (Localized Variants)

  • Small, firm, waxy papules, limited locations (upper/lower extremities, trunk)
  • Skin only; not associated with sclerosis, paraproteinemia, thyroid, or systemic involvement
  • May be associated with: HIV, HCV, toxic oil syndrome, L-tryptophan-associated myalgia-eosinophilia
Clinical Subtypes
  • Discrete papular: 2–5 mm symmetric papules, no face/sclerosis/systemic involvement
  • Acral persistent papular: dorsal hands/extensor forearms, females
  • Cutaneous mucinosis of infancy: neck, elbows, trunk; not self-healing
  • Pure nodular: nodular > papular
  • In HIV patients: discrete papular > acral persistent
Pathology & Treatment
  • Pathology: Mucin in dermis, minimal/absent fibrosis, variable fibroblasts
  • Treatment: No treatment needed in many cases; wait-and-see approach; spontaneous resolution possible
  • TCS/TCI may help; in HIV, oral isotretinoin may be effective

Self-Healing Cutaneous Mucinosis

  • Age: 1–15 years
  • Periarticular and periorbital subcutaneous nodules
  • Mild systemic symptoms: fever, arthralgia
  • No paraproteinemia, bone marrow, or thyroid dysfunction
  • Self-resolves within 1–8 months
Recall anchor:
IgG lambda is associated with scleromyxedema & systemic amyloidosis
IgG kappa is associated with necrobiotic xanthogranuloma & scleredema (Type II)

Scleredema

  • Symmetrical, diffuse induration of upper body (thickened dermis, mucin deposition)
  • Pathogenesis: Unknown; glycosylation of collagen, microvascular damage may contribute

Types of Scleredema

Type Association Location Demographics Frequency
Type 1 Streptococcal URTI Cervicofacial skin Children/middle-aged women 55%
Type 2 IgG kappa monoclonal gammopathy Cervicofacial skin Women 25%
Type 3 Diabetes mellitus Upper back Men 20%

All types: severe skin hardening/thickening ("board-like"), rare systemic involvement

Type I resolves spontaneously; Types II & III are chronic

Pathology & Treatment

Pathology:

  • Thickened reticular dermis
  • Large collagen bundles separated by mucin
  • Fenestration of dermis, normal fibroblast number, decreased elastin

Treatment:

  • UVA1 and PUVA are first-line
  • Treat plasma dyscrasia (type II: bortezomib)
  • Strict glycemic control (type III)
  • Physical therapy for disability
  • Steroids/steroid-sparing agents (variable results)

Localized (Pretibial) Myxedema

  • Cutaneous induration of shins due to mucin deposition
  • Associated with hyperthyroidism (Graves disease); goiter, exophthalmos, acropachy
  • 1–5% of Graves patients; can appear post-treatment even if hypothyroid
  • Unknown serum factor (not TSH Ig) incites fibroblasts
Clinical Features & Diagnosis

Clinical:

  • Erythematous/violaceous waxy indurated plaques/nodules
  • Peau d'orange appearance, non-pitting edema → elephantiasis
  • Anterolateral lower legs/feet

Differential Diagnosis:

  • Pruritic dermatoses, lichen simplex chronicus
  • Hypertrophic lichen planus, lichen amyloidosis
  • Lymphedema/lipedema
Pathology & Treatment

Pathology:

  • Large mucin deposits, thickened collagen
  • Subepidermal grenz zone, stellate fibroblasts
  • Perivascular/periadnexal lymphocytes, mast cells

Treatment:

  • Treatment of underlying thyroid dysfunction does NOT change skin lesion course
  • Screen for thyroid dysfunction
  • Intralesional/topical steroids under occlusion = first line
  • Compression stockings for lymphedema
  • Severe cases: IVIg, rituximab, plasmapheresis, octreotide

Generalized Myxedema

  • Severe primary hypothyroidism (not secondary)
  • Decreased mucin degradation

Age-Specific Clinical Features of Generalized Myxedema

(Click to reveal)

Age-Specific Presentations:

  • Congenital (cretinism): dwarfism, mental retardation, somnolence, constipation, poor feeding, periorbital/tongue/lip/genital puffiness, dry/cold/pale skin, brittle nails
  • Congenital (cretinism): dwarfism, mental retardation, somnolence, constipation, poor feeding, periorbital/tongue/lip/genital puffiness, dry/cold/pale skin, brittle nails
  • Congenital (cretinism): dwarfism, mental retardation, somnolence, constipation, poor feeding, periorbital/tongue/lip/genital puffiness, dry/cold/pale skin, brittle nails
  • Congenital (cretinism): dwarfism, mental retardation, somnolence, constipation, poor feeding, periorbital/tongue/lip/genital puffiness, dry/cold/pale skin, brittle nails
  • Congenital (cretinism): dwarfism, mental retardation, somnolence, constipation, poor feeding, periorbital/tongue/lip/genital puffiness, dry/cold/pale skin, brittle nails
  • Clavicular pad is diagnostic
  • Associated with maternal povidone iodine use
  • Adolescent: short stature, delayed development/maturity, hypertrichosis (shoulders/upper back)
  • Adult: MC, women 40–60, sluggishness, weight gain, cold intolerance, puffy eyelids/lips/tongue/hands, hoarse/slurred speech, pale/waxy/dry skin
  • Acquired ichthyosis (no sweating), yellow palms/soles (carotenoderma)
  • Diffuse non-scarring alopecia, lateral eyebrow loss, purpura, blue fingertips, delayed healing, xanthomas, myxedema coma (if untreated)
Pathology & Treatment

Pathology:

  • Perivascular/perifollicular mucin
  • Normal fibroblasts
  • Decreased elastin

Treatment:

  • Thyroxine replacement

Reticular Erythematous Mucinosis

  • Overlap with tumid lupus, Jessner's lymphocytic infiltration
  • Middle-aged women, exacerbated by heat, OCPs, pregnancy, radiation
  • Sun exposure as trigger is controversial
  • Fibroblasts stimulated by IL-1
  • Not associated with systemic disorders
Clinical Features & Diagnosis

Clinical:

  • Reticulated/annular erythematous papules/plaques
  • Smooth surface
  • Upper chest/back

Differential Diagnosis:

  • Jessner's lymphocytic infiltration (no mucin)
  • Tumid LE (DIF may help differentiate)
Pathology & Treatment

Pathology:

  • Interstitial mucin (upper dermis)
  • Perivascular/periadnexal lymphocytes
  • DIF negative (rarely IgM/IgA/C3 at DEJ)

Treatment:

  • Hydroxychloroquine/chloroquine clears in 1–2 months
  • TCS/TCI, antihistamines, tetracycline, cyclosporine
  • UVB, pulsed dye laser (variable results)

Histologic Stains for Mucin

PAS stains positive in basement membrane, fungi, glycogen; negative in acidic mucopolysaccharides (HA)

Colloidal iron stains blue

Stain Target Result Notes
Colloidal iron Acid MPS (sulfated/nonsulfated) Blue May add hyaluronidase to distinguish types
Alcian blue pH 2.5 Nonsulfated acid MPS (hyaluronic acid) Blue Mnemonic: "HIGH-luronic acid stains at HIGH pH"
Alcian blue pH 0.5 Sulfated acid MPS Blue Hyaluronic acid does NOT stain at pH 0.5
PAS Neutral MPS (BMZ, fungi, glycogen) Pink Does NOT stain acid MPS (hyaluronic acid)
Toluidine blue Acid MPS Red-purple Metachromatic; rarely used for mucin
Mucicarmine Epithelial mucin Pink-red Not good for dermal mucins

Diagnostic Criteria & Comparisons

Scleromyxedema vs Localized Lichen Myxedematosus

Feature Scleromyxedema Localized Lichen Myxedematosus
Clinical Generalized papular eruption, sclerodermoid features Papular/nodular eruption, plaques by papule confluence
Microscopy Mucin, fibroblast proliferation, fibrosis (triad) Mucin, variable fibroblast proliferation
Monoclonal gammopathy Present (IgG lambda) Absent
Thyroid disorder Absent Absent

Leonine Facies – Associated Dermatologic Diseases

Disorders Associated with Leonine Facies

  • Scleromyxedema
  • Lepromatous leprosy
  • Leishmaniasis
  • Cutaneous lymphoma (T-cell, rarely B-cell)
  • Actinic reticuloid (chronic actinic dermatitis)
  • Leukemia cutis
  • Systemic amyloidosis
  • Lipoid proteinosis
  • Mastocytosis (nodular)
  • Sarcoidosis
  • Multicentric reticulohistiocytosis
  • Progressive nodular histiocytosis
  • Pachydermoperiostosis

✨ Mnemonic for Leonine Facies: "SLICK LAMP" ✨

Scleromyxedema

Leprosy (lepromatous)

Infections (leishmaniasis)

Cutaneous lymphoma

Kutaneous leukemias (leukemia cutis)

Lipid disorders (lipoid proteinosis)

Amyloidosis (systemic)

Mastocytosis (nodular)

Progressive histiocytic disorders

Quick Review: MCQ High-Yield Points

  1. Hyaluronic acid - never sulfated, no core protein, not in Golgi
  2. Mucin stains: Colloidal iron, Alcian blue, Toluidine blue (CAT)
  3. IL-1 especially important in tumid lupus and REM
  4. Scleromyxedema: IgG lambda monoclonal gammopathy
  5. Scleredema Type 2: IgG kappa monoclonal gammopathy
  6. Localized myxedema: treatment of thyroid dysfunction does NOT affect skin
  7. Generalized myxedema: clavicular pad is diagnostic
  8. REM: hydroxychloroquine clears in 1-2 months
  9. Scleromyxedema therapy: IVIG first line
  10. Scleredema therapy: UVA1 and PUVA first line